Skip to content

Phase II The effect of automated cold compression therapy on pain and swelling in patients undergoing arthroscopic rotator cuff repair.

Phase II The effect of automated cold compression therapy on pain and swelling in patients undergoing arthroscopic rotator cuff repair.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260715006
Enrollment
52
Registered
2026-07-15
Start date
2027-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain and swelling following arthroscopic shoulder tendon repair, particularly rotator cuff repair, are conditions that can impair mobility, rehabilitation, and patients&#039

Interventions

Participants will receive postoperative therapy using an automated hot and cold compression device designed to provide controlled thermal compression according to the study protocol. The device will b
s instructions. The effectiveness in reducing pain, swelling, and analgesic consumption will be evaluated and compared with the investigational device during the postoperative period.
Experimental Device,Active Comparator Device
Automated Hot and Cold Compression Device,Automated Cold Compression Device (Game Ready)

Sponsors

Thammasat University Hospital
Lead Sponsor
Thammasat University
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing arthroscopic shoulder tendon repair at Thammasat University Hospital during both regular and after hours service periods 2. No history of cold sensitivity or allergic reactions to cold 3. No peripheral vascular diseases such as Buerger's disease 4. No diabetes mellitus with peripheral sensory neuropathy 5. No history of Raynaud's disease 6. No postoperative complications affecting consciousness or sensory function or requiring specific treatment such as shock or respiratory arrest 7. No history of morphine allergy or substance abuse 8. American Society of Anesthesiologists physical status class 1 to 3 9. Normal cognitive function vision hearing and communication ability 10. No psychiatric or neurological conditions affecting communication such as Alzheimer's disease or delirium 11. Patients receiving general anesthesia or regional anesthesia according to the treatment plan 12. Willingness to participate in the study and provide informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to participate or withdraw their informed consent during the study 2. Patients with a history of cold sensitivity or allergic reactions to cold 3. Patients with peripheral vascular diseases such as Buerger's disease or Raynaud's disease 4. Patients with diabetes mellitus associated with peripheral sensory neuropathy 5. Patients with a history of morphine allergy or substance abuse 6. Patients who develop postoperative complications affecting consciousness or sensory function or requiring urgent medical treatment such as shock or respiratory arrest 7. Patients with communication difficulties, visual or hearing impairments, or psychiatric or neurological disorders that may affect study assessments 8. Patients who are unable to complete follow up during the 36 hour postoperative period

Design outcomes

Primary

MeasureTime frame
Postoperative pain intensity Baseline, 12, 24, and 36 hours after surgery Visual Analog Scale ,Shoulder swelling Baseline, 12, 24, and 36 hours after surgery Standardized shoulder circumference measurement

Secondary

MeasureTime frame
Analgesic consumption Within 36 hours after surgery Total postoperative analgesic dose recorded from medical records,Patient satisfaction At 36 hours after surgery or before hospital discharge Percentage of patients reporting satisfaction based on a structured satisfaction questionnaire

Countries

Thailand

Contacts

Public ContactNuttakarn Koontorn

Thammasat University Hospital, Thammasat University

nut.kitty2010@gmail.com0622642429

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026